Hana Starobova is an early career research fellow at the Sensory Neuropharmacology Group at the University of Queensland (UQ). Her research focuses on the understanding of cancer therapy-induced adverse effects, including late effects and the development of mechanism-based prevention strategies. Hana’s long-term goal is to become a leading scientist conducting transformative science with translational potential and to create a research program bringing together researchers and clinicians who will work together towards innovative mechanism-based treatment strategies to improve the outcomes and the long-term impacts for cancer patients. Hana is an internationally recognised expert, and she has extensive experience in pharmacology, innate immunology, transcriptomics, rodent behavioural studies, target identification and in development of in vivo models.